Style | Citing Format |
---|---|
MLA | Varshosaz J, et al.. "Pegylated Trimethylchitosan Emulsomes Conjugated to Octreotide for Targeted Delivery of Sorafenib to Hepatocellular Carcinoma Cells of Hepg2." Journal of Liposome Research, vol. 29, no. 4, 2019, pp. 383-398. |
APA | Varshosaz J, Raghami F, Rostami M, Jahanian A (2019). Pegylated Trimethylchitosan Emulsomes Conjugated to Octreotide for Targeted Delivery of Sorafenib to Hepatocellular Carcinoma Cells of Hepg2. Journal of Liposome Research, 29(4), 383-398. |
Chicago | Varshosaz J, Raghami F, Rostami M, Jahanian A. "Pegylated Trimethylchitosan Emulsomes Conjugated to Octreotide for Targeted Delivery of Sorafenib to Hepatocellular Carcinoma Cells of Hepg2." Journal of Liposome Research 29, no. 4 (2019): 383-398. |
Harvard | Varshosaz J et al. (2019) 'Pegylated Trimethylchitosan Emulsomes Conjugated to Octreotide for Targeted Delivery of Sorafenib to Hepatocellular Carcinoma Cells of Hepg2', Journal of Liposome Research, 29(4), pp. 383-398. |
Vancouver | Varshosaz J, Raghami F, Rostami M, Jahanian A. Pegylated Trimethylchitosan Emulsomes Conjugated to Octreotide for Targeted Delivery of Sorafenib to Hepatocellular Carcinoma Cells of Hepg2. Journal of Liposome Research. 2019;29(4):383-398. |
BibTex | @article{ author = {Varshosaz J and Raghami F and Rostami M and Jahanian A}, title = {Pegylated Trimethylchitosan Emulsomes Conjugated to Octreotide for Targeted Delivery of Sorafenib to Hepatocellular Carcinoma Cells of Hepg2}, journal = {Journal of Liposome Research}, volume = {29}, number = {4}, pages = {383-398}, year = {2019} } |
RIS | TY - JOUR AU - Varshosaz J AU - Raghami F AU - Rostami M AU - Jahanian A TI - Pegylated Trimethylchitosan Emulsomes Conjugated to Octreotide for Targeted Delivery of Sorafenib to Hepatocellular Carcinoma Cells of Hepg2 JO - Journal of Liposome Research VL - 29 IS - 4 SP - 383 EP - 398 PY - 2019 ER - |